The clinical efficiency of antibacterial therapy , which had been evaluated both immediately after treatment termination and during further control , did not substantially differ in the furamag/cefotaxime combination and control groups although there was an obvious tendency towards the more marked effect of combined therapy 7-14 days after treatment ( 11.8 % efficiency differences ; p > 0.05 ) .